Maxx Orthopedics and Invibio Biomaterial Solutions were granted Investigational Device Exemption approval for application of Freedom Total Knee System with Invibio PEEK-OPTIMA Femoral Component, as a staged study.
The PEEK-OPTIMA femoral component is based on Maxx Orthopedics’ Freedom Total Knee high-flexion, bone-conserving design. As part of the partnership with Maxx Ortho, Invibio is involved in the development, knee performance testing and optimization, and knee component manufacturing using the polymer.
The study will compare the Freedom Total Knee using the PEEK-OPTIMA Femoral Component to a controlled registry of the same system using traditional metal femoral components.
“The approval of the IDE application for the Freedom Total Knee® System with PEEK-OPTIMA™ Femoral Component is a monumental achievement and the culmination of more than a decade of collaboration between Maxx Ortho and Invibio. It is incredibly satisfying to see this next step in the development of this innovation reaching fruition,” said Corey Perine, Chief Operating Officer, of Maxx Orthopedics.
Invibio is the medical division of Victrex. Jakob Sigurdsson, Victrex CEO said, “We believe this technology has the potential to be a game-changer for total knee replacement, so are excited to be able to further assess its benefits through rigorous clinical evaluation, building on the progress so far. We look forward to the study’s progression and remain optimistic about the transformative impact this pioneering device could have on the future of joint replacement.”
Maxx Orthopedics and Invibio Biomaterial Solutions were granted Investigational Device Exemption approval for application of Freedom Total Knee System with Invibio PEEK-OPTIMA Femoral Component, as a staged study.
The PEEK-OPTIMA femoral component is based on Maxx Orthopedics' Freedom Total Knee high-flexion, bone-conserving design. As part of...
Maxx Orthopedics and Invibio Biomaterial Solutions were granted Investigational Device Exemption approval for application of Freedom Total Knee System with Invibio PEEK-OPTIMA Femoral Component, as a staged study.
The PEEK-OPTIMA femoral component is based on Maxx Orthopedics’ Freedom Total Knee high-flexion, bone-conserving design. As part of the partnership with Maxx Ortho, Invibio is involved in the development, knee performance testing and optimization, and knee component manufacturing using the polymer.
The study will compare the Freedom Total Knee using the PEEK-OPTIMA Femoral Component to a controlled registry of the same system using traditional metal femoral components.
“The approval of the IDE application for the Freedom Total Knee® System with PEEK-OPTIMA™ Femoral Component is a monumental achievement and the culmination of more than a decade of collaboration between Maxx Ortho and Invibio. It is incredibly satisfying to see this next step in the development of this innovation reaching fruition,” said Corey Perine, Chief Operating Officer, of Maxx Orthopedics.
Invibio is the medical division of Victrex. Jakob Sigurdsson, Victrex CEO said, “We believe this technology has the potential to be a game-changer for total knee replacement, so are excited to be able to further assess its benefits through rigorous clinical evaluation, building on the progress so far. We look forward to the study’s progression and remain optimistic about the transformative impact this pioneering device could have on the future of joint replacement.”
Copy to clipboard 
